Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2009
View Archived Issues
Gilead enters agreement with Tibotec for fixed-dose Truvada and TMC-278
Read More
Anti-HIV activity seen with S/GSK-1349572 in preclinical and clinical studies
Read More
Gilead Sciences reports second quarter 2009 results
Read More
Anti-Abeta1-40 antibody PF-04360365 found safe and well tolerated in patients with mild AD
Read More
Sylentis receives approval to begin phase I studies with its antiglaucoma agent SYL-040012
Read More
Allergan receives FDA approval for Acuvail ophthalmic solution
Read More
Pharmaxis discloses SSAO/MAO inhibitors
Read More
Pooled data show asenapine efficacy in treating manic or mixed episodes in bipolar I disorder
Read More
Leo Pharma describes CaSR agonists for the treatment of hyperparathyroidism
Read More
Nevirapine as effective as atazanavir/ritonavir in HIV-1 patients given tenofovir DF/emtricitabine
Read More
Genecare Research Institute prepares and tests novel IKK-beta inhibitors
Read More
ARRY-872 targets Trk receptors for pain management
Read More
Affitech licenses anti-VEGF antibodies from Peregrine
Read More
Astellas and RegImmune sign agreement to develop new vaccine technology
Read More
Repros discontinues use of the Proellex 50-mg dose in clinical trials
Read More
EMEA reconfirms the safety of Lantus
Read More
FDA approves new indication for Lilly's osteoporosis drug Forteo
Read More
CHMP recommends approval for Ilaris in the treatment of CAPS
Read More
Dual Bcl-2 and microtubule antagonists claimed by Univ. Minnesota for prostate cancer therapy
Read More
Prolysis discovers novel DNA gyrase inhibitors as antibacterial agents
Read More
R-788 fails to meet efficacy endpoints in phase IIb trial in RA patients
Read More
European Commission approves Nycomed's Instanyl for breakthrough cancer pain
Read More
Cellceutix's cancer drug Kevetrin shows no significant toxicity indications in animal studies
Read More
Arno enrolls first patient in phase II AR-67 study for myelodysplastic syndrome
Read More
Promedior commences phase I PRM-151 trial in healthy volunteers
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe